Wells Fargo sets Henry Schein stock at Equal-weight with $80 PT
Wells Fargo (NYSE:WFC) initiated coverage of Henry Schein (NASDAQ:HSIC) shares with an Equal-weight rating and a price target of $80.00. The healthcare provider, currently valued at $9.68 billion, has ...
Henry Schein initiated with an Equal Weight at Wells Fargo
Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...
Benzinga.com15d
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Newsday16d
The oldest evidence for lead pollution comes from ancient Greece
WASHINGTON — Ancient Greece produced the earliest records of democracy, western philosophy — and, it turns out, lead pollution. Researchers studying sediment cores recovered from mainland ...
Tracks16d
WATCH: Ollie Henry and the Rusty team score in the Mentawai’s
It’s safe to say, the boys running the Mangalui did exactly that. Rusty team rider Ollie Henry has also packed a bunch of the footage into his latest edit ‘All Ollie Adventures ep 2: Mentawais Boat ...
Newsday16d
Henry Schein gets $250 million investment from private equity firm KKR
two of the firm's leaders will join Henry Schein’s board of directors, according to the announcement: Max Lin, a partner at KKR who leads its health care industry team, and William K.
AOL16d
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
Yahoo Finance16d
KKR builds stake in Henry Schein, reaches deal to add board seats
Under the agreement, Max Lin and William Daniel will join Henry Schein's board as independent directors. Lin is a partner at KKR where he leads the healthcare industry team. He will join the ...
Nasdaq16d
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...
Business Insider17d
Henry Schein announces $250M strategic investment by KKR, board changes
As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...
news.bloomberglaw17d
KKR Takes Strategic Stake in Medical Supplier Henry Schein (1)
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.